Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the Standard Care vs COrticosteroid for REtinal Vein Occlusion (SCORE) study: SCORE study report 14

Archives of Ophthalmology

Volumn 130, Issue 12, 2012, Pages 1517-1524

  Scott, Ingrid U ^a   VanVeldhuisen, Paul C ^b   Oden, Neal L ^b   Ip, Michael S ^c   Domalpally, Amitha ^c   Doft, Bernard H ^d   Elman, Michael J ^e   Blodi, Barbara A ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d Retina Vitreous Consultants   (United States)

^e Elman Retina Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTER POINT THICKNESS; CENTRAL RETINA VEIN OCCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; EYE CARE; FEMALE; HEMIRETINAL VEIN OCCLUSION; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINAL VEIN; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 84871181053     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2012.2728     Document Type: Article

References (18)

1. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98(3):271-282.
2. Sperduto RD, Hiller R, Chew E, et al. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the Eye Disease Case-Control Study. Ophthalmology. 1998;105(5):765-771.
3. Hayreh SS. Retinal vein occlusion. Indian J Ophthalmol. 1994;42(3):109-132.
4. Hayreh SS, Hayreh MS. Hemicentral retinal vein occlusion: pathogenesis, clinical features, and natural history. Arch Ophthalmol. 1980;98(9):1600-1609. (Pubitemid 10001106)
5. Chopdar A. Hemicentral retinal vein occlusion: pathogenesis, clinical features, natural history, and incidence of dual trunk central retinal vein. Trans Ophthalmol Soc U K. 1982;102(pt 2):241-248. (Pubitemid 13172093)
6. Chopdar A. Hemispheric retinal vein occlusion or hemicentral retinal vein occlusion. Arch Ophthalmol. 1986;104(8):1128-1130.
7. Sanborn GE, Magargal LE. Characteristics of the hemispheric retinal vein occlusion. Ophthalmology. 1984;91(12):1616-1626. (Pubitemid 15197038)
8. Gómez-Ulla de Irazazabal FJ, Cadarso Suarez L, Orduña Domingo E. Hemispheric retinal branch vein occlusions. Ophthalmologica. 1986;193(1-2):14-22.
9. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131(1):61-77. (Pubitemid 32037010)
10. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report. Ophthalmology. 1995;102(10):1425-1433.
11. Ip MS, Scott IU, VanVeldhuisen PC, et al SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs COrticosteroid for REtinal Vein Occlusion (SCORE) Study report 5 [published correction appears in Arch Ophthalmol. 2009;127(12):1648]. Arch Ophthalmol. 2009;127(9):1101-1114.
12. Scott IU, Ip MS, VanVeldhuisen PC, et al SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs COrticosteroid for REtinal Vein Occlusion (SCORE) Study report 6. Arch Ophthalmol. 2009;127(9):1115-1128.
13. Ip MS, Oden NL, Scott IU, et al SCORE Study Investigator Group. SCORE Study report 3: study design and baseline characteristics. Ophthalmology. 2009;116 (9):1770-1777.e1. doi:10.1016/j.ophtha.2009.03.022.
14. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the Early Treatment of Diabetic Retinopathy Study testing protocol. Am J Ophthalmol. 2003;135(2):194-205. (Pubitemid 36151797)
15. Scott IU, Blodi BA, Ip MS, et al SCORE Study Investigator Group. SCORE Study report 2: interobserver agreement between investigator and reading center classification of retinal vein occlusion type. Ophthalmology. 2009;116(4):756-761.
16. Scott IU, VanVeldhuisen PC, Oden NL, et al SCORE Study Investigator Group. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology. 2009;116(3):504-512.
17. Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology. 2011;118(1):119-133.e1-2. doi:10.1016/j.ophtha.2010.04.019.
18. Hayreh SS, Zimmerman MB. Hemicentral retinal vein occlusion: natural history of visual outcome. Retina. 2012;32(1):68-76.